Maurice Gregory JR. in Las Vegas, Nevada

Additional Medical Specialties Include:
GENERAL PRACTICE, PAIN MANAGEMENT

Medical School: Meharry Medical College School Of Medicine
Graduation Year: 1981
The Primary Medical Specialty for Maurice Gregory JR. is listed as: Addiction Medicine
Approximate Years of Experience: 43
PAC (PECOS ID)#: 5496882888
NPI #: 1548278617
NPI Created On: 08/04/2006
NPI Last Updated Listed as: 11/30/2019
Primary Taxonomy Code: 208D00000X
License Number:
4894
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Testing for presence of drug
3. Sars-cov-2 covid-19 amp prb
4. Established patient office or other outpatient visit, typically 5 minutes
5. Established patient office or other outpatient visit, typically 15 minutes
6. Established patient office or other outpatient, visit typically 25 minutes
7. Established patient office or other outpatient, visit typically 40 minutes
8. Initial hospital inpatient care, typically 70 minutes per day
9. Subsequent hospital inpatient care, typically 35 minutes per day
10. Established patient home visit, typically 60 minutes
11. Prolonged office or other outpatient service first hour
12. Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp
13. Physician supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of c
14. Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel
15. Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r